Project Grant R01GM163062
- Federal Project Grant Award Summary The Washington University received a Project Grant award of $427,625 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through July 31, 2030. The award supports fundamental research investigating the molecular mechanisms of compound microtubule structure and function within the mammalian centrosome-cilium complex. The research employs advanced...
- Federal Grant Award Summary The Washington University received a $912,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2025 through March 31, 2030. The award funds basic biomedical research investigating the spatiotemporal regulation of organelle interactions and metabolism, specifically examining how protein networks control lipid droplet growth and degradation. The...
- Federal Grant Award Summary The Washington University received a $410,520 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded April 1, 2026, with completion targeted for January 31, 2031. The award funds fundamental research investigating the molecular principles of intracellular electrochemistry, specifically examining how living systems establish and maintain buffering environments to...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Washington University a Project Grant totaling $326,550 under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This five-year award supports fundamental research aimed at developing ecological theory and computational methodologies to predict and design microbial ecosystem functions. The research addresses a...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $427,625 Project Grant to the University of Washington, effective September 1, 2025, through August 31, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). This award supports the development of capillaric microfluidics technology for integrated, self-powered, and self-regulated sample preparation in miniaturized mass spectrometry (MS) systems. The research addresses a...
- Federal Project Grant Award Summary Uforce Biotechnology, LLC received a $267,323 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) on May 15, 2025, with completion targeted for April 30, 2026. The award funds development of a quantum sensing device that integrates super-resolution force spectroscopy (SURFS) with ultrasound technology to accelerate drug development and improve screening...
- Federal Project Grant Summary The National Institute of General Medical Sciences (NIGMS) awarded The Washington University a $2.78 million Project Grant (CFDA 93.859: Biomedical Research and Research Training) effective September 1, 2025, through August 31, 2029. This award supports fundamental basic research investigating the role of the ribosome and translation factors in mediating cellular stress signaling. The research focuses on understanding how cells recognize and respond to chemical...
- Federal Grant Award Summary The University of Washington received a $2.1 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded May 1, 2026, with completion targeted for April 30, 2030. The award supports the development of ultrahigh multiplexing (>1000-plex) fluorescent probes and associated methods for spatial transcriptomics applications. The primary deliverable is a set of...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Washington University $1,943,750 under the Biomedical Research and Research Training program (CFDA 93.859) to conduct fundamental research on the regulation of the mitotic DNA damage response. The award, effective August 8, 2025, through July 31, 2029, supports investigator-initiated research aimed at understanding how cells regulate DNA repair mechanisms when double-strand breaks occur...
- Federal Project Grant Award Summary The Washington University received a $1.39M Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), effective September 1, 2025, through August 31, 2028. This award funds research on time-lapse epigenome profiling to advance cellular reprogramming technologies. The project will develop and apply novel methodologies to capture real-time snapshots of heterochromatin...
The Washington University received a $1.244M Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded April 1, 2026, with completion targeted for March 31, 2030. The award supports development of an integrated software-hardware platform that enables real-time, feedback-based control of mechanical forces on cells and engineered tissues—a capability absent from most current high-throughput drug development systems. The research team will integrate four key technologies: rapid algorithms for estimating tissue contractility, graphics processing unit (GPU)-accelerated computing, magnetically-responsive smart biomaterials, and high-throughput engineered tissue platforms into a user-friendly, graphical-user-interface (GUI)-supported system. The deliverables include optimization and validation of the Direct Deformation Estimation (DDE) algorithm to enable real-time computation of tissue deformation, integration of this software with hardware components that trigger magnetic responses based on imaging data, and demonstration of the integrated system through mechano-pharmacologic screening studies using skeletal and cardiac muscle tissues. The platform's adaptable software-to-hardware interface design is intended to be readily adoptable by the broader research community without requiring costly, specialized hardware approaches, thereby advancing the field's capacity to incorporate dynamic mechanical loading into drug discovery workflows.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.2m | 3/31/26 |